Physician profile
Matthew Wade Devaney
NPI 1740310465
$535.39
in general payments reported to CMS, 2019-2025
13 companies · $72.86 in 2025
The $72.86 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.93 · 2020: $13.30 · 2021: $41.16 · 2022: $36.19 · 2023: $193 · 2024: $153 · 2025: $72.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306 · Gift: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $305.82 |
| Gift | $112.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $277.17 | 2021-2024 | Opalescence |
| Envista Holdings Corporation | $40.21 | 2025 | Round Bur #6 |
| 3m Company | $29.50 | 2019-2023 | 3m Filtek, 3m Relyx |
| Henry Schein, INC. | $25.53 | 2019-2020 | |
| Straumann USA LLC | $24.96 | 2023 | |
| Dentsply Sirona INC | $21.19 | 2022 | |
| Kerr Corporation | $19.56 | 2023 | Endodontics |
| Nobel Biocare USA | $19.56 | 2023 | Nobelactive |
| Salvin Dental Specialties, INC. | $18.68 | 2021 | |
| Biohorizons Implant Systems INC. | $18.31 | 2025 | Biohorizons Dental Implants |
| Pacira Pharmaceuticals Incorporated | $15.00 | 2022 | |
| Align Technology, INC. | $14.34 | 2025 | Invisalign |
| Orapharma, A Division of Bausch Health US, LLC | $11.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Devaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.